We are thrilled to work with so many pharmaceutical and technology experts who share our desire to advance clinical patient data collection and ultimately lead researchers to better clinical decisions during drug development.”
Philadelphia, PA (PRWEB) June 16, 2016
ERT, a leading provider of high-quality patient data collection solutions for use in clinical drug development, today announced that its’ Innovation Lab will travel to the Drug Information Association (DIA) Annual Meeting to give clinical researchers access to advanced models for clinical trials and patient data collection.
The Traveling Lab is an extension of ERT’s permanent, Boston-based Innovation Lab, where pharmaceutical researchers and technological leaders collaborate with ERT scientists and engineers to determine if diverse technologies like wearables and mHealth devices can enhance patient data collected during clinical trials. The objective of the Lab is to advance electronic patient data capture, increase efficiencies and deliver more comprehensive patient insight and engagement during clinical development.
June 27-29 at the Philadelphia Convention Center
DIA attendees can visit booth #509 to immerse themselves in new technology simulations and experience the realities of patients and clinicians who might use these technologies in future clinical trials. Some of the concepts available for demonstration in the Traveling Lab include:
- Remote telemedicine solutions for at-home doctor visits and patient-accessible, real-time lab results
- Digital home health devices for personal health management and clinical data collection
- Virtual reality applications for clinical assessment, intervention and training
- Next generation, wireless spirometry and 12-lead ECG technologies to reduce clinical site burden and expense
“As a leader in innovative patient data capture methods, we recognize the value in collaboration when it comes to advancing clinical research processes,” said James Munz, Vice President, Innovation at ERT. “We are thrilled to work with so many pharmaceutical and technology experts who share our desire to advance clinical patient data collection and ultimately lead researchers to better clinical decisions during drug development.”
For additional information on the Innovation Lab and the Traveling Lab schedule,visit https://www.ert.com/innovation-lab.
ERT is a leading provider of high-quality patient data collection solutions for use in clinical drug development. ERT delivers a combination of technology, services and clinical consulting that increase the accuracy and reliability of patient data and improve the efficiency of the clinical development process. ERT delivers widely deployed solutions in centralized Cardiac Safety, Respiratory, and electronic Clinical Outcome Assessments (eCOA) – which includes patient-, clinician-, observer- and performance-reported outcomes – and cloud-based analytics and performance metrics. By efficiently integrating these solutions through a system built upon a scientific and regulatory foundation, ERT collects, analyzes and delivers safety and efficacy data critical to the approval, labeling and reimbursement of pharmaceutical products. For more information see http://www.ert.com. Join ERT on LinkedIn, Twitter, YouTube and Facebook,